Tri Locum Partners’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-545,532
| Closed | -$13.5M | – | 71 |
|
2022
Q2 | $13.5M | Buy |
545,532
+249,205
| +84% | +$6.18M | 5.54% | 5 |
|
2022
Q1 | $7.43M | Sell |
296,327
-139,973
| -32% | -$3.51M | 2.9% | 18 |
|
2021
Q4 | $15.9M | Buy |
436,300
+420,255
| +2,619% | +$15.3M | 6.25% | 5 |
|
2021
Q3 | $274K | Buy |
+16,045
| New | +$274K | 0.11% | 24 |
|
2021
Q1 | – | Sell |
-166,077
| Closed | -$10.3M | – | 77 |
|
2020
Q4 | $10.3M | Buy |
+166,077
| New | +$10.3M | 3.73% | 8 |
|